title: Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.
authors.affiliation: Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029-6574, USA. Valentin.Fuster@mssm.edu
authors.forename: Valentin
authors.initials: V
authors.lastname: Fuster
authors.forename: Deepak L
authors.initials: DL
authors.lastname: Bhatt
authors.forename: Robert M
authors.initials: RM
authors.lastname: Califf
authors.forename: Alan D
authors.initials: AD
authors.lastname: Michelson
authors.forename: Marc S
authors.initials: MS
authors.lastname: Sabatine
authors.forename: Dominick J
authors.initials: DJ
authors.lastname: Angiolillo
authors.forename: Eric R
authors.initials: ER
authors.lastname: Bates
authors.forename: David J
authors.initials: DJ
authors.lastname: Cohen
authors.forename: Barry S
authors.initials: BS
authors.lastname: Coller
authors.forename: Bruce
authors.initials: B
authors.lastname: Furie
authors.forename: Jean-Sebastien
authors.initials: JS
authors.lastname: Hulot
authors.forename: Kenneth G
authors.initials: KG
authors.lastname: Mann
authors.forename: Jessica L
authors.initials: JL
authors.lastname: Mega
authors.forename: Kiran
authors.initials: K
authors.lastname: Musunuru
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: O'Donnell
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Price
authors.forename: David J
authors.initials: DJ
authors.lastname: Schneider
authors.forename: Daniel I
authors.initials: DI
authors.lastname: Simon
authors.forename: Jeffrey I
authors.initials: JI
authors.lastname: Weitz
authors.forename: Marlene S
authors.initials: MS
authors.lastname: Williams
authors.forename: W Keith
authors.initials: WK
authors.lastname: Hoots
authors.forename: Yves D
authors.initials: YD
authors.lastname: Rosenberg
authors.forename: Ahmed A K
authors.initials: AA
authors.lastname: Hasan
mesh_terms: D035843:Biomedical Research / Q000639:trends*; D004305:Dose-Response Relationship, Drug; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D054555:National Heart, Lung, and Blood Institute (U.S.); D010597:Pharmacogenetics; D013927:Thrombosis / Q000517:prevention & control*; D014481:United States
chemical_list: D005343:Fibrinolytic Agents